Mundipharma and NUS Enterprise collaborate to provide global challenge to use tech to solve problems in cancer

April 17, 2019 - 3 minutes read

15 April 2019: Mundipharma and NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS), have announced the launch of the ‘Mundipharma Cancer Care Challenge’, which invites teams from around the world to submit game-changing ideas that use technology to solve problems that cancer patients and doctors face.

Jointly organized by Mundipharma and NUS Enterprise, the Challenge comprises three problem statements that individuals, or teams of up to four, can take on. The ultimate aim is to turn the ideas into actionable solutions that will benefit cancer patients all over the world.

Mundipharma CEO, Raman Singh, said: “We are delighted to be working with NUS Enterprise on this project. Our vision is to take a new approach to healthcare, underpinned by a vision to harness technology in order to provide game-changing healthcare solutions and deliver superior patient outcomes.

For this challenge, we’re leveraging open innovation by seeking ideas from the tech world and beyond. I’m looking forward to seeing the proposals that will be put forward and am full of hope about the impact the results will have. This is an opportunity for creative thinkers and innovators to help make a real difference to the lives of cancer sufferers.”
Roadshows for Q&A will be held in three locations around the world in advance and will be live streamed.  Full details are available at


About the Mundipharma Cancer Care Challenge

The Challenge is open to students, start-ups or anyone else that wishes to enter as an individual or as a team of up to four members. Submissions are currently open and close on June 2, 2019. Finalists will be flown to Singapore to pitch to judges at Innovfest Unbound 2019 and stand to gain mentoring, networking opportunities, exposure, industry insights, and potential funding and collaboration. Winners will receive a cash prize on top of this. Full details are available at


About Mundipharma

Mundipharma is a network of independent associated companies which are privately owned entities. Mundipharma is a prime example of an organization that consistently delivers high-quality medicines while standing by the values it represents. Its mission is to alleviate the suffering of patients and to substantially improve their quality of life. Mundipharma is dedicated to bringing to patients the benefit of novel treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare.

For more information please visit:

Mundipharma media contact:

Stephenie Vasko
Chief Communications Officer & Head, Digital Strategy | +65 6303 9732